Boundless Bio BOLD
NASDAQ BOLD
$2.56 -0.05 (-1.92%)
At close: Sep 29, 2026 · 4:00 PM EDT

Boundless Bio (BOLD) Operating Leases (2024 - 2026)

Updated

Boundless Bio's Operating Leases was $45 million in Q1 2026, down 6.8% from $48.31 million a year earlier and down 1.9% from the prior quarter.

Analysis

Boundless Bio (BOLD) Operating Leases (2024 - 2026) Analysis & Trends

At the end of FY2025, Operating Leases at Boundless Bio came in at $45.87 million, down 3.7% from FY2024.

  • In earlier years, Operating Leases was $47.63 million in FY2024.
  • Per Business Quant data, BOLD's Operating Leases in the three quarters before Q1 2026 was $45.87 million (Q4 2025), $46.71 million (Q3 2025) and $47.55 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Boundless Bio 58.66 Mn 58.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 45.00 Mn
Dec 31, 2025 45.87 Mn
Sep 30, 2025 46.71 Mn
Jun 30, 2025 47.55 Mn
Mar 31, 2025 48.31 Mn
Dec 31, 2024 47.63 Mn
API Access

Boundless Bio Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=BOLD&period=max&api_key=YOUR_API_KEY